Clinical trials
Myositis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 11 |
| 2025 | 22 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 26 |
| Not yet recruiting | 8 |
| Unknown status | 8 |
| Withdrawn | 4 |
| Enrolling by invitation | 3 |
| Suspended | 2 |
| Terminated | 1 |
| Completed | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China Immunotech (Beijing) Biotechnology Co., Ltd. | 6 |
| Peking University People's Hospital | 5 |
| Tongji Hospital | 5 |
| Nanjing Bioheng Biotech Co., Ltd. | 3 |
| Nanjing Legend Biotech Co. | 2 |
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2 |
| Qilu Hospital of Shandong University | 2 |
| RenJi Hospital | 2 |
| Shanghai Changzheng Hospital | 2 |
| argenx | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 54 |
| Lupus Erythematosus, Systemic | 33 |
| Scleroderma, Systemic | 30 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 25 |
| Sjogren's Syndrome | 17 |
| Antiphospholipid Syndrome | 13 |
| Autoimmune Diseases | 11 |
| Arthritis, Rheumatoid | 8 |
| Myasthenia Gravis | 6 |
| Dermatomyositis | 5 |
Trials
Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.